Biomarkers of cartilage turnover. Part 2: Non-collagenous markers

Veterinary Journal

Volumn 185, Issue 1, 2010, Pages 43-49

  Garvican, Elaine R ^a   Vaughan Thomas, Anne ^a   Clegg, Peter D ^a   Innes, John F ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Biomarkers; Metabolomics; Osteoarthritis; Proteoglycans

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; EPITOPE; FIBRONECTIN; GLYCOPROTEIN; KERATAN SULFATE; LINK PROTEIN; MONOCLONAL ANTIBODY; PROTEOGLYCAN; THROMBOSPONDIN; COLLAGEN TYPE 2; MATRILIN; SCLEROPROTEIN;

ANTIGEN DETECTION; ARTICULAR CARTILAGE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS FRAGMENTOGRAPHY; MENISCECTOMY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOARTHRITIS; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TURNOVER TIME; ANIMAL; DOG; DOG DISEASES; METABOLISM; VETERINARY;

ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; DOG DISEASES; DOGS; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; OSTEOARTHRITIS; PROTEOGLYCANS; MATRILIN PROTEINS;

EID: 77953670237     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.04.012     Document Type: Review

References (101)

1. Arai K., Misumi K., Carter S.D., Shinbara S., Fujiki M., Sakamoto H. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease. Equine Veterinary Journal 2005, 37:31-36.
2. Archer C.W., Morrison E.H., Bayliss M.T., Ferguson M.W. The development of articular-cartilage: II. The spatial and temporal patterns of glycosaminoglycans and small leucine-rich proteoglycans. Journal of Anatomy 1996, 189:23-35.
3. Arican M., Carter S.D., Bennett D., May C. Measurement of glycosaminoglycans and keratan sulfate in canine arthropathies. Research in Veterinary Science 1994, 56:290-297.
4. Bendele A.M., Hulman J.F. Spontaneous cartilage degeneration in guinea pigs. Arthritis and Rheumatism 1988, 31:561-565.
5. Blecher C., Yaqub R., Fawthrop F. Synovial fluid chondroitin and keratan sulfate epitopes, glycosaminoglycans and hyaluronan in arthritic and normal knees. Annals of the Rheumatic Diseases 1997, 56:299-307.
6. Brandt K.D., Thonar E.J.M. Lack of association between serum keratan sulfate concentrations and cartilage changes of osteoarthritis after transection of the anterior cruciate ligament in the dog. Arthritis and Rheumatism 1989, 32:647-651.
7. Campion G.V., McCrae F., Schnitzer T.J., Lenz M.E., Dieppe P.A., Thonar E.J. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis and Rheumatism 1991, 34:1254-1259.
8. Carlson C.S., Loeser R.F., Johnstone B., Tulli H.M., Dobson D.B., Caterson B. Osteoarthritis in Cynomolgus macaques. II. Detection of modulated proteoglycan epitopes in cartilage and synovial fluid. Journal of Orthopaedic Research 1995, 13:399-409.
9. Carlson C.S., Guilak F., Vail T.P., Gardin J.F., Kraus V.B. Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee. Journal of Orthopaedic Research 2002, 20:92-100.
10. Caterson B., Mahmoodian F., Sorrell J.M., Hardongham T.E., Bayliss M.T., Carney S.T. Modulation of native chondroitin sulfate structure in tissue development and in disease. Journal of Cell Science 1990, 97:411-417.
11. Caterson B., Hughes C.E., Johnstone B. Immunological markers of cartilage proteoglycans metabolism in animal and human osteoarthritis. Articular Cartilage and Osteoarthritis 1992, 415-427. Raven Press, New York, NY, USA. K.E. Kuettner (Ed.).
12. Caterson B., Hughes C.E., Roughley P., Mort J.S. Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis. Acta Orthopaedica Scandinavica 1995, 66:121-124.
13. Chaganti R.K., Kelman A., Lui L., Yao W., Javaid M.K., Bauer D., Nevitt M., Lane N.E. Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis and Cartilage 2008, 16:566-571.
14. Chan S.S., Kent G.N., Will R.K. A sensitive assay for the measurement of serum chondroitin sulfate 3B3(-) epitope levels in human rheumatic diseases. Clinical and Experimental Rheumatology 2001, 19:533-540.
15. Cope A.P. Measurement of glycosaminoglycan release from cartilage explants. Arthritis Research 2007, 201-209. Humana Press, Totowa, NJ, USA. J.S. Mort, P.J. Roughley (Eds.).
16. Damyanovich A.Z., Staples J.R., Chan A.D., Marshall K.W. Comparative study of normal and osteoarthritic canine synovial fluid using 500MHz 1H magnetic resonance spectroscopy. Journal of Orthopaedic Research 1999, 17:223-231.
17. Damyanovich A.Z., Staples J.R., Chan A.D., Marshall K.W. 1H MNR investigation of changes in the metabolic profile of synovial fluid in bilateral canine osteoarthritis with unilateral joint denervation. Osteoarthritis and Cartilage 1999, 7:165-172.
18. DiCesare P., Hauser N., Lehman D., Pasumarti S., Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Letters 1994, 354:237-240.
19. Di Cesare P.E., Carlson C.S.N., Stolerman E.S., Hauser N., Tulli H., Paulsson M. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. Journal of Orthopaedic Research 1996, 14:946-955.
20. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue. Biochemica et Biophysica Acta 1986, 883:173-177.
21. Fawthrop F., Yaqub R., Belcher C., Bayliss M., Doherty M. Chondroitin and keratan sulfate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis. Annals of the Rheumatic Diseases 1997, 56:119-122.
22. Fife G., Brandt K.D. Extracellular matrix of cartilage, Glycoproteins. Joint Cartilage Degradation 1993, 139-158. Marcel Dekker, New York, NY, USA. J.F. Woessner, D.S. Howell (Eds.).
23. Flannery C.R., Hughes C.E., Schumacher B.L., Tudor D., Aydelotte M.B., Kuettner K.E., Caterson B. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochemical and Biophysical Research Communications 1999, 254:535-541.
24. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis and Cartilage 2008, 16:1196-1204.
25. Fuller C.J., Barr A.R., Sharif M., Dieppe P.A. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis and Cartilage 2001, 9:49-55.
26. Ganu V., Goldberg R., Peppard J., Rediske J., Melton R., Hu S.-I. Inhibition of interleukin-1a-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors, potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis and Rheumatism 1998, 41:2143-2151.
27. Garvican E.R., Vaughan-Thomas A., Redmond C., Clegg P.D. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis. Connective Tissue Research 2008, 49:62-67.
28. Garvican E.R., Vaughan-Thomas A., Innes J.F., Clegg P.D. Biomarkers of cartilage turnover. part 1: markers of collagen degradation and synthesis. The Veterinary Journal 2010, 185:36-42.
29. Girling S.L., Bell S.C., Whitelock R.G., Rayward R.M., Thomson D.G., Carter S.C., Vaughan-Thomas A., Innes J.F. Use of biochemical markers of osteoarthritis to investigate the potential disease-modifying effect of tibial plateau levelling osteotomy. Journal of Small Animal Practice 2006, 47:708-714.
30. Glant T.T., Mikecz K., Roughley P.J., Buzas E., Poole A.R. Age-related changes protein-related epitopes of human articular-cartilage proteoglycans. Biochemical Journal 1986, 236:71-75.
31. Glasson S.S., Askew R., Sheppard B. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
32. Halasz K., Kassner A., Morgelin M., Heinegard D. COMP acts as a catalyst in collagen fibrillogenesis. Journal of Biological Chemistry 2007, 282:31166-31173.
33. Hardingham T.E., Fosang A.J. Review, Proteoglycans, many forms and many functions. The FASEB Journal 1992, 6:861-870.
34. Hazell P.K., Dent C., Fairclough J.A. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis and Rheumatism 1995, 38:953-959.
35. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., Sommarin Y., Wendel M., Oldberg A., Heinegård D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. Journal of Biological Chemistry 1992, 267:6132-6136.
36. Hegemann N., Kohn B., Brunnberg L., Schmidt M.F. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis and Cartilage 2002, 10:714-721.
37. Helal I.E., Misumi K., Tateno O., Kodama T., Ishimaru M., Yamamoto J., Miyakoshi D., Fujiki M. Effect of exercise on serum concentration of cartilage oligomeric matrix protein in Thoroughbreds. American Journal of Veterinary Research 2007, 68:134-140.
38. Huebner J.L., Hanes M.A., Beekman B., TeKoppele J.M., Kraus V.B. A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis and Cartilage 2002, 10:758-767.
39. Hughes C.E., Caterson B., Fosang A.J. Monoclonal antibodies that specifically recognise neoepitope sequences generated by aggrecanase and matrix metalloproteinase cleavage of aggrecan-application to catabolism in situ and in vitro. Biochemistry Journal 1995, 305:799-804.
40. Hummel K.M., Neidhart M., Vilim V., Hauser N., Aicher W.K., Gay R.E., Gay S., Häuselmann H.J. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. British Journal of Rheumatology 1998, 37:721-728.
41. Innes J.F., Sharif M., Barr A.R.S. Relations between biochemical markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. American Journal of Veterinary Research 1998, 59:1530-1536.
42. Innes J.F., Sharif M., Barr A.R.S. Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. American Journal of Veterinary Research 1999, 60:1164-1168.
43. Innes J.F., Little C.B., Hughes C.E., Caterson B. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis. American Journal of Veterinary Research 2005, 66:1679-1685.
44. Johnson K.A., Hay C.W., Chu Q., Kochevar D., Hulse D.A. Concentration of chondroitin sulfate epitopes 3B3 and 7D4 in synovial fluid after intra-articular and extracapsular reconstruction of the cranial cruciate ligament in dogs. American Journal of Veterinary Research 2001, 62:581-587.
45. Johnson K.A., Hay C.W., Chu Q., Roe S.C., Caterson B. Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. American Journal of Veterinary Research 2002, 63:775-781.
46. Kong S.Y., Stabler T.V., Criscione L.G., Elliott A.L., Jordan J.M., Kraus V.B. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis and Rheumatism 2006, 54:2496-2504.
47. Kraus V.B., Huebner J.L., Stabler T., Flahiff C.M., Setton L.A., Fink C., Vilim V., Clark A.G. Ascorbic acid increases the severity of spontaneous knee osteoarthritis in a guinea pig model. Arthritis and Rheumatism 2004, 50:1822-1831.
48. Lamers R.A.N., DeGroot J., Spies-Faber E.J., Jellema R.H., Kraus V.B., Verzijl N., TeKoppele J.M., Spijksma G.K., Vogels J.T.W.E., van der Greef J., van Nesselrooij J.H.J. Identification of disease- and nutrient-related metabolic fingerprints in Osteoarthritic guinea-pigs. Journal of Nutrition 2003, 133:1776-1780.
49. Lamers R.A.N., van Nesselrooij J.H.J., Kraus V.B., Jordan J.M., Renner J.B., Dragomir A.D., Luta G., van der Greef J., DeGroot J. Identification of a urinary metabolite profile associated with osteoarthritis. Osteoarthritis and Cartilage 2005, 13:762-768.
50. Lin P., Chen C., Torzilli P.A. Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis and Cartilage 2004, 12:485-496.
51. Lindhorst E., Vail T.P., Guilak F., Wang H., Setton L.A., Vilim V., Kraus V.B. Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis. Journal of Orthopaedic Research 2000, 18:269-280.
52. Lindon J.C., Nicholson J.K., Wilson I.D. Directly coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences 2000, 748:233-258.
53. Little C., Smith S., Ghosh P. Histomorphological and immunohistochemical evaluation of joint changes in a model of osteoarthritis induced by lateral meniscectomy in sheep. Journal of Rheumatology 1997, 24:2199-2209.
54. Little C.B., Flannery C.R., Hughes C.E., Goodship A., Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochemical Journal 1999, 344:61-68.
55. Little C.B., Flannery C.R., Hughes C., Goodship A., Caterson B. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis and Cartilage 2005, 13:162-170.
56. Lorenzo P., Bayliss M.T., Heinegard D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biology 2004, 6:381-391.
57. Loulakis P., Shrikhande A., Davis G., Maniglia C.A. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage. Biochemical Journal 1992, 284:589-593.
58. Majumdar M.K., Askew R., Schelling S., Stedman N., Blanchet T., Hopkins B., Morris E.A., Glasson S.S. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis and Rheumatism 2007, 56:3670-3674.
59. Manicourt D.H., Lenz M.E., Thonar E.J. Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. Journal of Rheumatology 1991, 18:1872-1876.
60. Matyas J.R., Atley L., Ionescu M., Eyre D., Poole A.R. Analysis of cartilage biomarkers in the early phases of canine osteoarthritis. Arthritis and Rheumatism 2003, 50:543-548.
61. Mazzuca S.A., Poole A.R., Brandt K.D., Katz B.P., Lane K.A., Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. Journal of Rheumatology 2006, 33:1147-1151.
62. McDevitt C.A., Muir H. Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog. Journal of Bone and Joint Surgery 1976, 58:94-101.
63. Meyers S.L., Brandt K.D., Eilam O. Even low-grade synovitis significantly accelerates the clearance of protein from the canine knee. Implications for measurement of synovial fluid markers of osteoarthritis. Arthritis and Rheumatism 1995, 38:1085-1091.
64. Misumi K., Vilim V., Clegg P.D., Thompson C.C., Carter S.D. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids. Osteoarthritis and Cartilage 2001, 9:119-127.
65. Misumi K., Vilim V., Hatazoe T., Murata T., Fujiki M., Oka T., Sakamoto H., Carter S.D. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis. Equine Veterinary Journal 2002, 34:602-608.
66. Misumi K., Vilim V., Carter S.D., Ichihashi K., Oka T., Sakamoto H. Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy. American Journal of Veterinary Research 2002, 63:598-603.
67. Misumi K., Tagami M., Kamimura T., Miyakoshi D., Helal I.E., Arai K., Fujiki M. Urine cartilage oligomeric matrix protein (COMP) measurement is useful in discriminating the osteoarthritic Thoroughbreds. Osteoarthritis and Cartilage 2006, 14:1174-1180.
68. Müller G., Michel A., Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connective Tissue Research 1998, 39:233-244.
69. Neame P.J., Barry F.P. The link proteins. Review. Experientia 1993, 49:393-402.
70. Neidhart M., Hauser N., Paulsson M., DiCesare P.E., Michel B.A., Häuselmann H.J. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. British Journal of Rheumatology 1997, 36:1151-1160.
71. Nganvongpanit K., Itthiarbha A., Ong-Chai S., Kongtawelert P. Evaluation of serum chondroitin sulfate and hyaluronan, biomarkers of osteoarthritis in canine hip dysplasia. Journal of Veterinary Science 2008, 9:317-325.
72. Oldberg A., Antonsson P., Lindblom K., Heinegård D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. Journal of Biological Chemistry 1992, 267:22346-22350.
73. Piróg K.A., Jaka O., Katakura Y., Meadows R.S., Kadler K.E., Boot-Handford R.P., Briggs M.D. A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia. Human Molecular Genetics 2010, 19:52-64.
74. Plaas A.H.K., Wong-Palms S., Roughley P.J. Chemical and immunological assay of the non-reducing terminal residues of chondroitin sulfate from human aggrecan. Journal of Biological Chemistry 1997, 272:20603-20610.
75. Poole A.R. Cartilage in health and disease. Arthritis and Allied Conditions. A Textbook of Rheumatology 2001, 226-284. Lippincott, Williams and Wilkins, Philadelphia, PA, USA. W. Koopman (Ed.).
76. Prattay M.A., Su J.L., Leesnitzer M.A., Struglics A., Larsson S., Lohmander L.S., Kumar S. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Osteoarthritis and Cartilage 2006, 14:702-713.
77. Ratcliffe A., Beauvais P.J., Fatemah S.-M. Synovial fluid analyses detect and differentiate proetoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy. Agents and Actions 1993, 39:63-67.
78. Rayan V., Thonar E.J., Chen L.M., Lenz M.E., Williams J.M. Regional differences in the rise in blood levels of antigenic keratan sulfate and hyaluronan after chymopapain induced knee joint injury. Journal of Rheumatology 1998, 25:521-526.
79. Recklies A.D., Baillargeon L., White C. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis and Rheumatism 1998, 41:997-1006.
80. Rodriguez E., Roughley P. Link protein can retard the degradation of hyaluronan in proteoglycan aggregates. Osteoarthritis and Cartilage 2006, 14:823-829.
81. Rosenberg K., Olsson H., Mörgelin M., Heinegård D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. Journal of Biological Chemistry 1998, 273:20397-20403.
82. Salisbury C., Sharif M. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood. Annals of the Rheumatic Diseases 1997, 56:558-561.
83. Sandy J.D. Editorial: A contentious issue finds some clarity, on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis and Cartilage 2006, 14:95-100.
84. Saxne T., Heinegard D. Cartilage oligomeric matrix protein, a novel marker of cartilage turnover detectable in synovial fluid and blood. British Journal of Rheumatology 1992, 31:583-591.
85. Sharif M., Granell R., Johansen J., Clarke S., Elson C., Kirwan J.R. Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Rheumatology 2006, 45:522-526.
86. Skiöldebrand E., Heinegård D., Eloranta M.L., Nilsson G., Dudhia J., Sandgren B., Ekman S. Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds. Journal of Orthopaedic Research 2005, 23:156-163.
87. Slater R.R., Bayliss M.T., Lachiewicz P.F. Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis and Rheumatism 1995, 38:655-659.
88. Smith R.K., Heinegård D. Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury. Equine Veterinary Journal 2000, 32:52-58.
89. Sorrel J.M., Mahmoodian F., Schafer I.A., Davis B., Caterson B. Identification of monoclonal antibodies that recognise novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains, their use in mapping functionally distinct domains of human skin. Journal of Histochemistry and Cytochemistry 1990, 38:393-402.
90. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., Little C.B., Last K., Farmer P.J., Campbell I.K., Fourie A.M., Fosang A.J. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005, 434:648-652.
91. Struglics A., Larsson S., Pratta M.A., Kumar S., Lark M.W., Lohmander L.S. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis and Cartilage 2006, 14:101-113.
92. Taylor S.E., Weaver M.P., Pitsillides A.A., Wheeler B.T., Wheeler-Jones C.P., Shaw D.J., Smith R.K. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. Equine Veterinary Journal 2006, 38:502-507.
93. Thonar E.J., Lenz M.E., Klintworth G.K. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis and Rheumatism 1997, 28:1367-1376.
94. van Meurs J., van Lent P., Holthuysen A., Lambrou D., Bayne E., Singer I., van den Berg W. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis, a pivotal role for stromelysin-1 in cartilage destruction. Journal of Immunology 1999, 163:5633-5639.
95. Vilim V., Lenz M.E., Vytasek R., Masuda K., Pavelka K., Kuettner K.E., Thonar E.J. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. Archives of Biochemistry and Biophysics 1997, 341:8-16.
96. Weckworth W. Metabolomics in systems biology. Annual Review of Plant Biology 2003, 54:669-689.
97. Whiteman P. The quantitative measurement of Alcian Blue-glycosaminoglycan complexes. Biochemistry Journal 1973, 131:343-350.
98. Whitfield P.D., German A.J., Noble P.M. Metabolomics, an emerging post-genomic tool for nutrition. British Journal of Nutrition 2004, 92:549-555.
99. Wilson C.G., Palmer A.W., Zuo F., Eugui E., Wilson S., Mackenzie R., Sandy J.D., Levenston M.E. Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties. Matrix Biology 2006, 26:259-268.
100. Winter G.M., Poole C.A., Ilic M.Z., Ross J.M., Robinson H.C., Handley C.J. Identification of distinct metabolic pools of aggrecan and their relationship to type VI collagen in the chondrons of mature bovine articular cartilage explants. Connective Tissue Research 1998, 37:277-293.
101. Yamanokuchi K., Tagami M., Nishimatsu E., Shimizu Y., Hirose Y., Komatsu K., Misumi K. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum. Equine Veterinary Journal 2009, 41:41-46.